Skip to main content
HR 3683 117th Congress House Government Operations and Politics

Securing America’s Pharmaceutical Supply Chain Act

Introduced: June 1, 2021 Introduced by: Stauber, Pete Republican · Minnesota See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 1, 2021
Referred to the Subcommittee on Trade.
Jun 1, 2021
Referred to the Committee on Oversight and Reform, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 1, 2021
Introduced in House
 Plain-English summary Congressional Research Service

Securing America's Pharmaceutical Supply Chain Act

This bill allows an executive agency to purchase a drug approved or licensed by the Food and Drug Administration only if the drug is over 50% sourced, manufactured, and assembled in the United States.

This requirement may be waived (1) if the drug is not available in sufficient quantity or quality as over 50% sourced, manufactured, and assembled in the United States; or (2) during an emergency.

The U.S. Trade Representative (USTR) shall modify U.S. product coverage under all free trade agreements and the World Trade Organization Agreement on Government Procurement to exclude coverage of essential medicines and medical countermeasures. Subsequent to such modifications, the USTR shall make any necessary corresponding modifications of existing waivers and notify the Office of Management and Budget.

What's happening now June 1, 2021

Referred to the Subcommittee on Trade.

 Committees of jurisdiction 3
 Cosponsors 1
All 1 Democratic 1